Sakurai A - Search Results

1

Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.

Sakurai A, Imai T, Kikumori T, Horiuchi K, Okamoto T, Uchino S, Kosugi S, Suzuki S, Suyama K, Yamazaki M, Sato A; MEN Consortium of Japan. Sakurai A, et al. Clin Endocrinol (Oxf). 2013 Feb;78(2):248-54. doi: 10.1111/j.1365-2265.2012.04467.x. Clin Endocrinol (Oxf). 2013. PMID: 22690831

2

Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves' disease.

Hashizume K, Ichikawa K, Nishii Y, Kobayashi M, Sakurai A, Miyamoto T, Suzuki S, Takeda T. Hashizume K, et al. Among authors: sakurai a. J Clin Endocrinol Metab. 1992 Jul;75(1):6-10. doi: 10.1210/jcem.75.1.1642700. J Clin Endocrinol Metab. 1992. PMID: 1642700

3

Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.

Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T. Hashizume K, et al. Among authors: sakurai a. N Engl J Med. 1991 Apr 4;324(14):947-53. doi: 10.1056/NEJM199104043241403. N Engl J Med. 1991. PMID: 1900575 Free article. Clinical Trial.

4

Counterregulation of nuclear 3,5,3'-triiodo-L-thyronine (T3) binding by oxidized and reduced-nicotinamide adenine dinucleotide phosphates in the presence of cytosolic T3-binding protein in vitro.

Hashizume K, Miyamoto T, Yamauchi K, Ichikawa K, Kobayashi M, Ohtsuka H, Sakurai A, Suzuki S, Yamada T. Hashizume K, et al. Among authors: sakurai a. Endocrinology. 1989 Apr;124(4):1678-83. doi: 10.1210/endo-124-4-1678. Endocrinology. 1989. PMID: 2924718

5

Transcriptional regulation of human thyroid hormone receptor beta 1 gene expression: effect of human retinoid X receptor and identification of a transcriptional silencer region.

Sakurai A, Suzuki S, Katai M, Miyamoto T, Kobayashi H, Nakajima K, Ichikawa K, DeGroot LJ, Hashizume K. Sakurai A, et al. Mol Cell Endocrinol. 1995 Apr 28;110(1-2):103-12. doi: 10.1016/0303-7207(95)03522-9. Mol Cell Endocrinol. 1995. PMID: 7672440

6

Response of hepatic proteins to 3,5,3'-tri-iodo-L-thyronine in diabetic rats.

Takeda T, Ichikawa K, Kobayashi M, Miyamoto T, Suzuki S, Nishii Y, Sakurai A, Nagasawa T, Katai M, Nakajima K, et al. Takeda T, et al. Among authors: sakurai a. J Endocrinol. 1994 Oct;143(1):55-63. doi: 10.1677/joe.0.1430055. J Endocrinol. 1994. PMID: 7964322

7

Genetic screening in hereditary multiple endocrine neoplasia type 1: absence of a founder effect among Japanese families.

Sakurai A, Katai M, Itakura Y, Nakajima K, Baba K, Hashizume K. Sakurai A, et al. Jpn J Cancer Res. 1996 Sep;87(9):985-94. doi: 10.1111/j.1349-7006.1996.tb02130.x. Jpn J Cancer Res. 1996. PMID: 8878463 Free PMC article.

8

Gs alpha mutation may be uncommon in patients with multiple endocrine neoplasia type 1.

Sakurai A, Katai M, Furihata K, Hashizume K. Sakurai A, et al. J Clin Endocrinol Metab. 1996 Jun;81(6):2394-6. doi: 10.1210/jcem.81.6.8964883. J Clin Endocrinol Metab. 1996. PMID: 8964883

9

Multiple endocrine neoplasia type 1 is not rare in Japan.

Katai M, Sakurai A, Itakura Y, Ikeo Y, Nakajima K, Hara M, Iijima S, Kaneko T, Kobayashi M, Ichikawa K, Aizawa T, Hashizume K. Katai M, et al. Among authors: sakurai a. Endocr J. 1997 Dec;44(6):841-5. doi: 10.1507/endocrj.44.841. Endocr J. 1997. PMID: 9622300 Free article.

10

Novel MEN1 gene mutations in familial multiple endocrine neoplasia type 1.

Sakurai A, Shirahama S, Fujimori M, Katai M, Itakura Y, Kobayashi S, Amano J, Fukushima Y, Hashizume K. Sakurai A, et al. J Hum Genet. 1998;43(3):199-201. doi: 10.1007/s100380050070. J Hum Genet. 1998. PMID: 9747036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

748 results

Search Page